文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

预测 COVID-19 患者住院时间延长的因素。

Predictors of prolonged hospitalization of COVID-19 patients.

机构信息

Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.

School of Medicine, University of Zagreb, Zagreb, Croatia.

出版信息

Eur Geriatr Med. 2023 Jun;14(3):511-516. doi: 10.1007/s41999-023-00787-w. Epub 2023 Apr 27.


DOI:10.1007/s41999-023-00787-w
PMID:37103661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10133912/
Abstract

PURPOSE: Despite the importance of hospital bed network during the pandemic, there are scarce data available regarding factors predictive of prolonged length of hospitalization of COVID-19 patients. METHODS: We retrospectively analyzed a total of 5959 consecutive hospitalized COVID-19 patients in period 3/2020-6/2021 from a single tertiary-level institution. Prolonged hospitalization was defined as hospital stay > 21 days to account for mandatory isolation period in immunocompromised patients. RESULTS: Median length of hospital stay was 10 days. A total of 799 (13.4%) patients required prolonged hospitalization. Factors that remained independently associated with prolonged hospitalization in multivariate analysis were severe or critical COVID-19 and worse functional status at the time of hospital admission, referral from other institutions, acute neurological, acute surgical and social indications for admission vs admission indication of COVID-19 pneumonia, obesity, chronic liver disease, hematological malignancy, transplanted organ, occurrence of venous thromboembolism, occurrence of bacterial sepsis and occurrence of Clostridioides difficile infection during hospitalization. Patients requiring prolonged hospitalization experienced higher post-hospital discharge mortality (HR = 2.87, P < 0.001). CONCLUSIONS: Not only severity of COVID-19 clinical presentation but also worse functional status, referral from other hospitals, certain indications for admission, certain chronic comorbidities, and complications that arise during hospital stay independently reflect on the need of prolonged hospitalization. Development of specific measures aimed at improvement of functional status and prevention of complications might reduce the length of hospitalization.

摘要

目的:尽管医院床位网络在大流行期间很重要,但关于预测 COVID-19 患者住院时间延长的因素的数据却很少。

方法:我们回顾性分析了 2020 年 3 月至 2021 年 6 月期间,一家三级医院连续收治的 5959 例 COVID-19 住院患者。延长住院时间定义为住院时间超过 21 天,以计入免疫功能低下患者的强制性隔离期。

结果:中位住院时间为 10 天。共有 799 例(13.4%)患者需要延长住院时间。多变量分析中与延长住院时间相关的独立因素包括严重或危重症 COVID-19 和住院时功能状态较差、来自其他医疗机构的转诊、急性神经、急性外科和社会入院指征而非 COVID-19 肺炎入院指征、肥胖、慢性肝病、血液系统恶性肿瘤、移植器官、住院期间发生静脉血栓栓塞、细菌性败血症和艰难梭菌感染。需要延长住院时间的患者出院后死亡率更高(HR=2.87,P<0.001)。

结论:不仅 COVID-19 临床表现的严重程度,而且功能状态较差、来自其他医疗机构的转诊、某些入院指征、某些慢性合并症以及住院期间发生的并发症都会独立反映出需要延长住院时间。制定旨在改善功能状态和预防并发症的具体措施可能会缩短住院时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cdb/10133912/bea5454e99fb/41999_2023_787_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cdb/10133912/bea5454e99fb/41999_2023_787_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cdb/10133912/bea5454e99fb/41999_2023_787_Fig1_HTML.jpg

相似文献

[1]
Predictors of prolonged hospitalization of COVID-19 patients.

Eur Geriatr Med. 2023-6

[2]
Altered mental status predicts length of stay but not death in a community-based cohort of hospitalized COVID-19 patients.

Clin Neurol Neurosurg. 2021-11

[3]
Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients.

Croat Med J. 2022-2-28

[4]
Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.

World J Gastroenterol. 2021-12-14

[5]
Racial Disparities in the Risk for Thromboembolic Events in COVID-19 Patients during the Height of the SARS-CoV-2 Pandemic and Impact on Outcomes.

Ann Vasc Surg. 2022-11

[6]
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.

Trials. 2021-1-11

[7]
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.

Trials. 2020-10-28

[8]
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.

Trials. 2021-5-17

[9]
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.

JAMA Netw Open. 2021-12-1

[10]
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.

JAMA Intern Med. 2020-10-1

引用本文的文献

[1]
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective.

Infect Dis Ther. 2025-4

[2]
The congruence between the preferred and actual places of death among terminal cancer patients in China.

Front Psychol. 2024-9-10

[3]
Outcomes in COVID-19 Patients with Acute Cholangitis: A Single-Center Retrospective Analysis.

Medicina (Kaunas). 2024-8-20

[4]
Relationship of Anxiety, Depression, Stress, and Post-Traumatic Stress Disorder Symptoms with Disease Severity in Acutely Ill Hospitalized COVID-19 Patients.

Behav Sci (Basel). 2023-9-1

[5]
Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients.

Life (Basel). 2023-8-7

本文引用的文献

[1]
Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

Croat Med J. 2022-12-31

[2]
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.

Biomedicines. 2022-11-11

[3]
A novel evidence-based predictor tool for hospitalization and length of stay: insights from COVID-19 patients in New York city.

Intern Emerg Med. 2022-10

[4]
Absence of negativization of nasal swab test and frailty as risk factors for mortality in elderly COVID-19 patients admitted in long-term care facilities.

Eur Geriatr Med. 2022-8

[5]
Determinants and reasons for coronavirus disease 2019 vaccine hesitancy in Croatia.

Croat Med J. 2022-2-28

[6]
The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry.

Croat Med J. 2022-2-28

[7]
Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: Differences between vector and mRNA vaccines.

J Med Virol. 2022-6

[8]
Waning immunity six months after BioNTech/Pfizer COVID-19 vaccination among nursing home residents in Zagreb, Croatia.

Croat Med J. 2021-12-31

[9]
An update to the custom-made MS Excel workbook performing the log-rank test with extended functionality and a new original COVID-19 training data set.

Croat Med J. 2021-10-31

[10]
Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019.

Int J Clin Pract. 2021-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索